Suur Biliciler

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    J&J
    Topic:
    Imaavy
    Date added:
    07/09/2026
    Date updated:
    07/11/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    UCB
    Topic:
    Rystigo/Zylbrysq
    Date added:
    07/09/2026
    Date updated:
    07/11/2026
    Relationship end date:
    08/31/2027
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Amgen
    Topic:
    Uplizna
    Date added:
    07/11/2026
    Date updated:
    07/11/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    OctaPharma
    Topic:
    IVIG
    Date added:
    07/11/2026
    Date updated:
    07/11/2026
    Relationship end date:
    10/17/2025
Return to Closing Gaps in Idiopathic Inflammatory Myopathies: Advancing Evidence-Based Diagnosis and Evolving Therapeutic Strategies